Related content

MR thermometry-based feedback control of efficacy and safety in minimum-time thermal therapies: Phantom and in-vivo evaluations

By Arora Dhiraj   Cooley Daniel   Perry Trent   Guo Junyu   Richardson Andrew   Moellmer Jeff   Hadley Rock   Parker Dennis   Skliar Mikhail   Roemer Robert B.  

International Journal of Hyperthermia, Vol. 22, Iss. 1, 2006-02 ,pp. : 29-42

Informa Healthcare

Access to resources Recommend Favorite

Membrane Receptor and Antiangiogenic Targeted Therapies in the Treatment of Cancer

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 51-61

Bentham Science Publishers

Access to resources Recommend Favorite

Thermodynamics and Electro-Biologic Prospects for Therapies to Intervene in Cancer Progression

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 158-169

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic agents - clinical trial design and therapies in development

By Deplanque G.   Harris A.L.  

European Journal of Cancer, Vol. 36, Iss. 13, 2000-08 ,pp. : 1713-1724

Elsevier

Access to resources Recommend Favorite

Norcantharidin: A potential antiangiogenic agent for gallbladder cancers in vitro and in vivo

By          

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1501-1514

Spandidos Publications

Access to resources Recommend Favorite